Biodesix Inc (BDSX) is down 17.50% Thursday In Premarket Trading

Biodesix Inc (BDSX) has fallen Thursday morning, with the stock losing -17.50% in pre-market trading to 1.65. BDSX's short-term technical score of 56 indicates that the stock has traded more bullishly over the last month than 56% of stocks on the market. In the Diagnostics & Research industry, which ranks 127 out of 146 industries, BDSX ranks higher than 71% of stocks. Biodesix Inc has risen 98.02% over the past month, closing at $1.05 on November 3. During this period of time, the stock fell as low as $1.02 and as high as $2.00. BDSX has an average analyst recommendation of Strong Buy. The company has an average price target of $7.33.

BDSX has an Overall Score of 69. Find out what this means to you and get the rest of the rankings on BDSX!

See Full BDSX Report

Biodesix Inc has a Long-Term Technical rank of 60. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 40% of the market scoring higher. In the Diagnostics & Research industry which is number 123 by this metric, BDSX ranks better than 123% of stocks.

Important Dates for Investors in BDSX:

-Biodesix Inc is set to release earnings on 2/1/2023. Over the last 12 months, the company has reported EPS of $-1.73. -We do not have a set dividend date for Biodesix Inc at this time. Click Here To Get The Full Report on Biodesix Inc (BDSX)